Childhood Asthma Research and Education (CARE) Network Trial - Montelukast or Azithromycin for Reduction of Inhaled Corticosteroids in Childhood Asthma (MARS)

Stopped The CARE Network DSMB recommended to the NHLBI that the MARS trial be terminated, based on a futility analysis with 55 randomized children.

Conditions

• Asthma

Interventions

• DRUG: Budesonide + Salmeterol + Azithromycin
• DRUG: Budesonide + Salmeterol + Montelukast
• DRUG: Budesonide + Salmeterol + Placebo

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)